[EN] BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS<br/>[FR] COMPOSÉS BENZAMIDES ET IMIDAZOPYRAZINES UTILISÉS COMME INHIBITEURS DE LA BTK
申请人:MERCK SHARP & DOHME
公开号:WO2016106623A1
公开(公告)日:2016-07-07
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, or their use in therapy.
Pyrolysis of three acetates of methylbicyclo[2.2.1]heptan-2-ols and the parent alcohols
作者:Pirjo Vainiotalo、Esko Pohjala、Pentti Mälkönen
DOI:10.1039/p29850001537
日期:——
several temperatures and the product distribution determined. The mechanism and direction of elimination in relation to structure are discussed qualitatively. The formation of the principal products is consistent with a concerted elimination involving a six-membered cyclic transition state. Wagner–Meerwein rearrangement occurs as a competing reaction in cases where the formation of a tertiary structure
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.